Stock Market Reviews

Read and share opinions on DMAC (DiaMedica Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

Latest News

• DiaMedica Therapeutics Inc (DMAC) Q3 2025 Earnings Call Highlights: Promising Clinical Advances ...
  Nov 13, 2025
• DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
  Nov 12, 2025
• DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
  Nov 10, 2025
• DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
  Nov 6, 2025
• DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
  Sep 29, 2025
• DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?
  Sep 17, 2025
• Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
  Sep 8, 2025
• DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
  Sep 5, 2025
• DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
  Sep 2, 2025
• What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?
  Aug 28, 2025
• Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect?
  Aug 19, 2025
• DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
  Aug 12, 2025
• DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer
  Aug 6, 2025
• DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025
  Aug 5, 2025
• DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement
  Jul 23, 2025